30x Whole Genome Sequencing by Nebula Genomics. Begin a lifetime of discovery with full access to your genomic data, weekly updates based on the latest scientific discoveries, advanced ancestry analysis, and powerful genome exploration tools.
A Silicon Valley startup just launched a DNA-based health test that could be a big competitor to 23andMe
A new genetic test looks at your risk of diseases like cancer and high cholesterol. Unlike 23andMe's test, it includes genetic counseling and full sequencing.
A 23andMe competitor just launched its own cancer testing initiative — but it differs in a key way
Investor Vinod Khosla announced that consumer genetics company Color Genomics would offer testing for cancer and high cholesterol through a partnership with several leading universities. He made the announcement on Sunday at the HLTH conference in Las Vegas.
High quality libraries for human WGS with direct saliva Input
Representatives from Illumina and DNA Genotek explain how the Nextera DNA Flex and Oragene DNA from saliva kits are complementary technologies enabling direct saliva input in the creation of high-quality libraries for WGS.
COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing, research and data. Indiana Life Sciences Innovators Working to Combat COVID-19 LEARN MORE
COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing,
In-Depth: Consumer genomics and the road to legitimacy
More than a decade ago, when most people were still using not-so-smart mobile phones, the first human genome was sequenced. It cost $3 billion. In the time it took for smartphones to become the essential consumer technology, DNA sequencing rapidly evolved from a costly, uncommonly used process into a quick, reliable, relatively cheap and widely used predictive tool to give insight on disease risk and personalized treatment. Today, DNA sequencing – largely carried out by San Diego-based Illumina – has since become a critical part of healthcare technology.
Digitization at the pharmacy: shoring up the patient journey | Good Rebels
Changes in both the healthcare system and the consumer profile are leading the pharmacy towards an evolution from a small medicinal dispensary to a well-being
United Airlines Becomes First U.S. Carrier to Make COVID-19 Tests Available to Customers
United teams up with GoHealth Urgent Care and Color to make COVID-19 testing easy to obtain for customers traveling from San Francisco International to Hawaii
COVID-19 Testing & Surveillance for Large Populations
Color enables fast, accurate, COVID-19 testing and surveillance for large populations, with a high-capacity, CLIA-certified lab, an integrated infrastructure, and full program logistics. Learn more.
Reach 1.000.000 citizens until August 2020 with our tool "TRUST IN SCIENCE" to support decreasing the COVID-19 infection curve and mortality rates and lead to cost reduction and fraud prevention.
The University's strategic goals, as outlined in the WMU Strategic Plan 2016-2019, its Business Plan 2016-2017 and its current Business Plan 2018-2019, are fully aligned with the UN 2030 Agenda for Sustainable Development.
2019 Edelman Trust Barometer reveals major shift—and largest-ever trust gap
The very notion of “trust” appears to be in a tailspin, according to a variety of research over the last few years. Government, business, media—you name it, people are increasingly skeptical of it. Comms giant
Next-generation sequencing (NGS), also known as high-throughput sequencing, is the catch-all term used to describe a number of different modern sequencing technologies including: Illumina (Solexa) sequencing Roche 454 sequencing Ion torrent: Proton / PGM sequencing SOLiD sequencing These recent technologies allow us to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing, and as such have revolutionised the study of genomics and molecular biology. The next few pages will give you an overview of how Illumina, 454 and Ion torrent sequencing work.
A new kid on the consumer genomics block - MedCity News
Genos, a new consumer genomics platform, officially launched on Thursday with a different approach and some unusual selling points. It's starting with whole exome sequencing, charging more, and giving customers a chance to sell their own genetic data.